Toffoli G - Search Results

1

Pharmacogenetic relevance of MTHFR polymorphisms.

Toffoli G, De Mattia E. Toffoli G, et al. Pharmacogenomics. 2008 Sep;9(9):1195-206. doi: 10.2217/14622416.9.9.1195. Pharmacogenomics. 2008. PMID: 18781847 Review.

2

Effect of methylenetetrahydrofolate reductase 677C-->T polymorphism on toxicity and homocysteine plasma level after chronic methotrexate treatment of ovarian cancer patients.

Toffoli G, Russo A, Innocenti F, Corona G, Tumolo S, Sartor F, Mini E, Boiocchi M. Toffoli G, et al. Int J Cancer. 2003 Jan 20;103(3):294-9. doi: 10.1002/ijc.10847. Int J Cancer. 2003. PMID: 12471611 Free article.

3

Methylenetetrahydrofolate reductase 677 C-->T polymorphism and risk of proximal colon cancer in north Italy.

Toffoli G, Gafà R, Russo A, Lanza G, Dolcetti R, Sartor F, Libra M, Viel A, Boiocchi M. Toffoli G, et al. Clin Cancer Res. 2003 Feb;9(2):743-8. Clin Cancer Res. 2003. PMID: 12576444

4

Pharmacogenetics of stomach cancer.

Toffoli G, Cecchin E. Toffoli G, et al. Suppl Tumori. 2003 Sep-Oct;2(5):S19-22. Suppl Tumori. 2003. PMID: 12914384 Review.

5

Methylenetetrahydrofolate reductase genotype in diffuse large B-cell lymphomas with and without hypermethylation of the DNA repair gene O6-methylguanine DNA methyltransferase.

Toffoli G, Rossi D, Gaidano G, Cecchin E, Boiocchi M, Carbone A. Toffoli G, et al. Int J Biol Markers. 2003 Jul-Sep;18(3):218-21. doi: 10.1177/172460080301800310. Int J Biol Markers. 2003. PMID: 14535593 Free article.

6

Pharmacogenomics and stomach cancer.

Toffoli G, Cecchin E. Toffoli G, et al. Pharmacogenomics. 2004 Sep;5(6):627-41. doi: 10.1517/14622416.5.6.627. Pharmacogenomics. 2004. PMID: 15335285 Review.

7

Uridine diphosphoglucuronosyl transferase and methylenetetrahydrofolate reductase polymorphisms as genomic predictors of toxicity and response to irinotecan-, antifolate- and fluoropyrimidine-based chemotherapy.

Toffoli G, Cecchin E. Toffoli G, et al. J Chemother. 2004 Nov;16 Suppl 4:31-5. doi: 10.1179/joc.2004.16.Supplement-1.31. J Chemother. 2004. PMID: 15688606 Review.

8

Sarcomas and pharmacogenetics.

Biason P, Toffoli G. Biason P, et al. Among authors: toffoli g. Pharmacogenomics. 2005 Sep;6(6):585-601. doi: 10.2217/14622416.6.6.585. Pharmacogenomics. 2005. PMID: 16142999 Review.

9

Clinical implications of genetic polymorphisms on stomach cancer drug therapy.

Toffoli G, Cecchin E. Toffoli G, et al. Pharmacogenomics J. 2007 Apr;7(2):76-80. doi: 10.1038/sj.tpj.6500405. Epub 2006 Jun 27. Pharmacogenomics J. 2007. PMID: 16801937 Review. No abstract available.

10

MTHFR and ALL risk: a challenge.

Toffoli G, Innocenti F. Toffoli G, et al. Leuk Lymphoma. 2006 Jul;47(7):1203-4. doi: 10.1080/10428190600725461. Leuk Lymphoma. 2006. PMID: 16923547 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

345 results

Search Page